High-content phenotypic assay for proliferation of human iPSC-derived cardiomyocytes identifies L-type calcium channels as targets
Over 5 million people in the United States suffer from heart failure, due to the limited ability to regenerate functional cardiac tissue. One potential therapeutic strategy is to enhance proliferation of resident cardiomyocytes. However, phenotypic screening for therapeutic agents is challenged by t...
Saved in:
Published in | Journal of molecular and cellular cardiology Vol. 127; pp. 204 - 214 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.02.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Over 5 million people in the United States suffer from heart failure, due to the limited ability to regenerate functional cardiac tissue. One potential therapeutic strategy is to enhance proliferation of resident cardiomyocytes. However, phenotypic screening for therapeutic agents is challenged by the limited ability of conventional markers to discriminate between cardiomyocyte proliferation and endoreplication (e.g. polyploidy and multinucleation). Here, we developed a novel assay that combines automated live-cell microscopy and image processing algorithms to discriminate between proliferation and endoreplication by quantifying changes in the number of nuclei, changes in the number of cells, binucleation, and nuclear DNA content. We applied this assay to further prioritize hits from a primary screen for DNA synthesis, identifying 30 compounds that enhance proliferation of human induced pluripotent stem cell-derived cardiomyocytes. Among the most active compounds from the phenotypic screen are clinically approved L-type calcium channel blockers from multiple chemical classes whose activities were confirmed across different sources of human induced pluripotent stem cell-derived cardiomyocytes. Identification of compounds that stimulate human cardiomyocyte proliferation may provide new therapeutic strategies for heart failure.
[Display omitted]
•Novel automated hybrid live/fixed assay for cardiomyocyte proliferation.•Assay distinguishes proliferation from multinucleation and polyploidization.•Assay applied for high-content screening of compounds.•L-type calcium channel blockers induce cardiomyocyte proliferation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 LAW, ATP, QDW, and JJS conceived the research. LAW, MD, HA, and LD performed the experiments. LAW, ST, MD, ATP, OE, IB, and MF performed data analysis. ST, PA, MJW, SB, DLB, QDW and JJS contributed to experimental design, data interpretation, and manuscript revision. LAW and JJS wrote the manuscript. AUTHOR CONTRIBUTIONS |
ISSN: | 0022-2828 1095-8584 1095-8584 |
DOI: | 10.1016/j.yjmcc.2018.12.015 |